Sage Therapeutics Inc. (SAGE)
7.21
-0.09 (-1.23%)
At close: Mar 03, 2025, 3:59 PM
7.04
-2.29%
Pre-market: Mar 04, 2025, 05:48 AM EST
Sage Therapeutics Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 41.24M | 86.45M | 7.69M | 6.31M | 1.11B | 6.87M | 90.27M | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 9.44M | 2.16M | 813K | 553K | 565K | 400K | 1.1M | 500K | 281K | 115K | n/a | n/a | n/a |
| Gross Profit | 31.8M | 84.3M | 6.87M | 5.75M | 1.11B | 6.47M | 89.17M | -500K | -281K | -115K | n/a | n/a | n/a |
| Operating Income | -432.37M | -579.85M | -546.99M | -460.91M | 596.23M | -708.12M | -393.24M | -273.15M | -160.16M | -94.65M | -33.81M | -18.28M | -9.63M |
| Interest Income | 31.68M | 38.74M | 14.19M | 2.88M | 9.6M | 27.8M | 20.33M | 3.1M | 1.21M | 178K | 8K | 1K | n/a |
| Pretax Income | -400.67M | -541.49M | -532.78M | -457.89M | 606.07M | -680.24M | -372.88M | -270.12M | -158.99M | -94.5M | -33.81M | -18.28M | -9.63M |
| Net Income | -400.67M | -541.49M | -503.27M | -450.83M | 606.07M | -650.15M | -372.88M | -270.12M | -158.99M | -94.5M | -33.81M | -18.28M | -9.63M |
| Selling & General & Admin | 216.42M | 274.52M | 227.7M | 183.5M | 196.95M | 345.78M | 201.4M | 62.88M | 39.41M | 25.29M | 9.71M | 3.38M | 2.4M |
| Research & Development | 225.9M | 356.24M | 326.16M | 283.17M | 292.71M | 368.81M | 282.11M | 210.28M | 120.76M | 69.36M | 24.1M | 14.36M | 7.23M |
| Other Expenses | 21.85M | 33.39M | 15K | 134K | 250K | 82K | 22K | -64K | -35K | -23K | -9K | -3K | -1K |
| Operating Expenses | 464.17M | 630.76M | 553.86M | 466.66M | 489.67M | 714.59M | 483.51M | 273.15M | 160.16M | 94.65M | 33.81M | 18.28M | 9.63M |
| Interest Expense | n/a | n/a | 14.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 44.6M | 11.18M | 5.27M | 3.08M | n/a | n/a | n/a |
| Cost & Expenses | 473.61M | 666.69M | 554.67M | 467.22M | 490.23M | 714.99M | 483.51M | 273.15M | 160.16M | 94.65M | 33.81M | 18.28M | 9.63M |
| Income Tax | n/a | n/a | -29.52M | -7.07M | 15.52M | -30.09M | 20.36M | -3.63M | -1.49M | -293K | -59K | 2K | n/a |
| Shares Outstanding (Basic) | 60.77M | 59.84M | 59.31M | 58.67M | 51.98M | 50.83M | 46.12M | 38.1M | 33.47M | 27.78M | 21.57M | 16.77M | 16.77M |
| Shares Outstanding (Diluted) | 60.77M | 59.84M | 59.31M | 58.67M | 53M | 50.83M | 46.12M | 38.11M | 33.49M | 27.78M | 21.57M | 24.96M | 24.96M |
| EPS (Basic) | -6.59 | -9.05 | -8.49 | -7.68 | 11.66 | -12.79 | -8.08 | -7.09 | -4.75 | -3.4 | -1.57 | -1.09 | -0.57 |
| EPS (Diluted) | -6.59 | -9.05 | -8.49 | -7.68 | 11.43 | -12.79 | -8.08 | -7.09 | -4.75 | -3.4 | -1.57 | -0.73 | -0.39 |
| EBITDA | -409.49M | -545.07M | -545.87M | -456.73M | 626.6M | -705.84M | -392.1M | -269.62M | -160.16M | -94.65M | -33.81M | -18.23M | -9.59M |
| Depreciation & Amortization | 1.03M | 1.39M | 1.12M | 4.18M | 2.63M | 2.28M | 1.1M | 500K | 281K | 115K | 51K | 47K | 44K |